CERVARIX also contains

From: Teresa binstock

Nov 28, 2008 ... CERVARIX also contains
3-Odesacyl-4' - monophosphoryl lipid A (MPL),
aluminium hydroxide, sodium chloride, sodium phosphate-monobasic and ...

Cervarix is Approved in Australia for Females 10-45 Years Old
May 21, 2007 ... Cervarix information from
Drugs.com, includes Cervarix side effects, ...
formulated with conventional aluminum hydroxide adjuvant alone5. ...
http://www.drugs.com/newdrugs/cervarix-approved-australia- females-10-45

File Format: PDF/Adobe Acrobat - View as HTML
Administration in March 2007 for CERVARIX®, the
proposed name for the GSK cervical cancer
candidate vaccine ... of aluminum salt alone. GSK’s AS04 is unique ...

Cervical Cancer Vaccines: Cervarix™
In addition to two VLPs, the vaccine also
contains chemicals (aluminum ... Those receiving
Cervarix™ received three doses of the vaccine over a six month ...

GSK's Cervical Cancer Candidate Vaccine Cervarix™ Receives ...
Cervarix is a trademark of the GlaxoSmithKline
group of companies. ... with the MPL/aluminum
salt combination (AS04) compared to aluminium salt only. ...

Cervarix is a vaccine against certain types of
the human papillomavirus (HPV). ... Adjuvant
system 04 (AS04), contains an aluminum salt and monophosphoryl ...

Medical literature for aluminum hydroxide and for ASO4 suggests that
a subgroup of injectees will be inclined towards arthritic processes
and neurodegeneration. Cervarix seems like a way to augment sales of
methotrexate and related pharmeceuticals.


8. Aluminum adjuvant linked to Gulf War illness induces motor neuron
death in mice.
Petrik MS et al. Neuromolecular Med. 2007;9(1):83- 100. PMID: 17114826

from the abstract: ...Behavioral testing showed motor deficits in the
aluminum treatment group that expressed as a progressive decrease in
strength measured by the wire-mesh hang test (final deficit at 24 wk;
about 50%). Significant cognitive deficits in water-maze learning
were observed in the combined aluminum and squalene group (4.3 errors
per trial) compared with the controls (0.2 errors per trial) after 20
wk. Apoptotic neurons were identified in aluminum-injected animals
that showed significantly increased activated caspase-3 labeling in
lumbar spinal cord (255%) and primary motor cortex (192%) compared
with the controls. Aluminum-treated groups also showed significant
motor neuron loss (35%) and increased numbers of astrocytes (350%) in
the lumbar spinal cord. The findings suggest a possible role for the
aluminum adjuvant in some neurological features associated with GWI
and possibly an additional role for the combination of adjuvants.

9: Blood-brain barrier flux of aluminum, manganese, iron and other
metals suspected to contribute to metal-induced neurodegeneration.
Yokel RA. J Alzheimers Dis. 2006 Nov;10(2-3): 223-53. Review.

10: Aluminum complexing enhances amyloid beta protein penetration of
blood-brain barrier.
Banks WA, Niehoff ML, Drago D, Zatta P. Brain Res. 2006 Oct
20;1116(1):215- 21. Epub 2006 Aug 30.

11: Some aspects of astroglial functions and aluminum implications
for neurodegeneration.
Aremu DA, Me****suka S. Brain Res Rev. 2006 Aug 30;52(1):193- 200.

12: Nanomolar aluminum induces pro-inflammatory and pro-apoptotic
gene expression in human brain cells in primary culture.
Lukiw WJ, Percy ME, Kruck TP. J Inorg Biochem. 2005 Sep;99(9):1895-8.